Discover how innovative physical therapy, smart medications, nutrition strategies and mind-body techniques are transforming ...

A novel analysis of more than 375 published studies concluded that the association between chronic pain and rates of depression and anxiety is staggering. The study found that 40% of adults with ...

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

The Food and Drug Administration (FDA) has granted Fast Track designation to LTG-001 for the treatment of acute pain. LTG-001, an oral Nav1.8 selective ...

According to joint experts, the best pillows for shoulder pain depend on sleep style, loft, fill and more. See our top 9 ...

The company previously announced data from another Phase III trial of cebranopadol, which also met its primary endpoint.

目前，对于疼痛超敏（Pain hypersensitivity）的研究，已经知道它源于外周和脊髓体感神经元的可塑性变化，这些变化会改变向大脑传递的伤害性输入，进而影响疼痛感知。然而，作为传递伤害性信息到大脑的主要通路 —— 前外侧束（anterolateral tract，ALT），在不同疼痛状态下的功能组织却尚未完全明确。以往对 ALT ...

Tris Pharma’s first-in-class oral dual-NMR agonist achieved its primary endpoint in the ALLEVIATE-2 study by demonstrating a ...

Topline results were announced from a phase 3 trial evaluating cebranopadol for the treatment of moderate to severe acute pain in patients following ...